Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-Center, Double-Phase, Randomized, Double-Blind, Placebo Controlled (12-Week Double-Blind Followed by 12-Week Open-Label) Study Evaluating the Effect of Tolterodine ER on Urgency Urinary Incontinence (UUI), Urgency, Frequency, Sexual Quality of Life and Sexual Function in Women With Overactive Bladder
Brief Summary: The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Mirabegron 25 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mirabegron | Arm Label: Mirabegron 50 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mirabegron | Arm Label: Solifenacin 2.5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin succinate | Arm Label: Solifenacin 5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin succinate | Arm Label: Solifenacin 10 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin succinate | Arm Label: Solifenacin 2.5 mg and Mirabegron 25 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Arm Label: Solifenacin 2.5 mg and Mirabegron 50 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Arm Label: Solifenacin 5 mg and Mirabegron 25 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Arm Label: Solifenacin 5 mg and Mirabegron 50 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Arm Label: Solifenacin 10 mg and Mirabegron 25 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Arm Label: Solifenacin 10 mg and Mirabegron 50 mg; Type: EXPERIMENTAL; Interventions: Drug: Mirabegron, Drug: Solifenacin succinate | Intervention Type: DRUG; Name: Mirabegron; Assigned to Arm(s): Mirabegron 25 mg, Mirabegron 50 mg, Solifenacin 10 mg and Mirabegron 25 mg, Solifenacin 10 mg and Mirabegron 50 mg, Solifenacin 2.5 mg and Mirabegron 25 mg, Solifenacin 2.5 mg and Mirabegron 50 mg, Solifenacin 5 mg and Mirabegron 25 mg, Solifenacin 5 mg and Mirabegron 50 mg | Intervention Type: DRUG; Name: Solifenacin succinate; Assigned to Arm(s): Solifenacin 10 mg, Solifenacin 10 mg and Mirabegron 25 mg, Solifenacin 10 mg and Mirabegron 50 mg, Solifenacin 2.5 mg, Solifenacin 2.5 mg and Mirabegron 25 mg, Solifenacin 2.5 mg and Mirabegron 50 mg, Solifenacin 5 mg, Solifenacin 5 mg and Mirabegron 25 mg, Solifenacin 5 mg and Mirabegron 50 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Tolterodine ER 4mg QD; Assigned to Arm(s): N/A
C: Arm Label: I.Solifenacin succinate 10mg (2x5mg 1/day); Type: EXPERIMENTAL; Interventions: Drug: Solifenacin Succinate | Arm Label: II.Solifenacin succinate 5mg (5mg 1/day); Type: EXPERIMENTAL; Interventions: Drug: Solifenacin Succinate | Arm Label: III.Oxybutynin hydrochloride 15mg (5mg 3/day); Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxybutynin Hydrochloride | Arm Label: IV. Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): I.Solifenacin succinate 10mg (2x5mg 1/day) | Intervention Type: DRUG; Name: Solifenacin Succinate; Assigned to Arm(s): II.Solifenacin succinate 5mg (5mg 1/day) | Intervention Type: DRUG; Name: Oxybutynin Hydrochloride; Assigned to Arm(s): III.Oxybutynin hydrochloride 15mg (5mg 3/day) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): IV. Placebo
D: Arm Label: Botox A; Type: EXPERIMENTAL; Interventions: Drug: Botulinum toxin A (Botox A®) | Arm Label: Standardized Anticholinergic Regimen; Type: ACTIVE_COMPARATOR; Interventions: Drug: Solifenacin 5mg, Drug: Solifenacin 10mg, Drug: Trospium chloride | Intervention Type: DRUG; Name: Botulinum toxin A (Botox A®); Assigned to Arm(s): Botox A | Intervention Type: DRUG; Name: Solifenacin 5mg; Assigned to Arm(s): Standardized Anticholinergic Regimen | Intervention Type: DRUG; Name: Solifenacin 10mg; Assigned to Arm(s): Standardized Anticholinergic Regimen | Intervention Type: DRUG; Name: Trospium chloride; Assigned to Arm(s): Standardized Anticholinergic Regimen

Answer: B